Charlotte's Web Holdings (CWBHF) Return on Capital Employed (2022 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Return on Capital Employed of 29.66% for Q1 2026, up 174.0% year-over-year from 10.83% in Q1 2025, and down 2.11% quarter-over-quarter from 29.05% in Q4 2025.
Charlotte's Web Holdings (CWBHF) Return on Capital Employed (2022 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Return on Capital Employed for 5 consecutive years, with 29.66% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 174.0% year-over-year to 29.66%; the TTM figure through Mar 2026 stood at 29.66% (up 174.0% YoY), while the FY2025 annual figure was 23.65%, up 368.0% from the prior year.
- Return on Capital Employed eased to 29.66% in Q1 2026 per CWBHF's latest filing, from 29.05% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 23.84% in Q2 2025 and bottomed at 103.78% in Q3 2022.
- Historically, Return on Capital Employed has averaged 44.6% across 5 years, with a median of 32.45% in 2024.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 6832 bps — and 2024, when it tumbled 161 bps.
- Charlotte's Web Holdings' Return on Capital Employed stood at 36.79% in 2022, then climbed by 18 bps to 30.18% in 2023, then fell by 5 bps to 31.79% in 2024, then rose by 9 bps to 29.05% in 2025, then slipped by 2 bps to 29.66% in 2026.
- Business Quant data shows CWBHF's Return on Capital Employed at 29.66% in Q1 2026, 29.05% in Q4 2025, and 26.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | -29.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.92% |
| Mar 31, 2026 | -29.66% |
| Dec 31, 2025 | -29.05% |
| Sep 30, 2025 | -26.51% |
| Jun 30, 2025 | -23.84% |
| Mar 31, 2025 | -31.40% |
| Dec 31, 2024 | -31.79% |
| Sep 30, 2024 | -34.07% |
| Jun 30, 2024 | -36.50% |
| Mar 31, 2024 | -32.45% |
| Dec 31, 2023 | -30.18% |
| Sep 30, 2023 | -42.81% |
| Jun 30, 2023 | -35.28% |
| Mar 31, 2023 | -32.32% |
| Dec 31, 2022 | -36.79% |
| Sep 30, 2022 | -103.78% |
| Jun 30, 2022 | -103.60% |
| Mar 31, 2022 | -98.10% |